In early January, major pharmacies CVS and Walgreens announced that they will take advantage of a new Biden administration rule granting them permission to distribute the chemical-abortion drug mifepristone, which now accounts for more than half of all abortions in the U.S. A couple of weeks later, rival company Rite Aid announced that it will do the same, dispensing abortion drugs at a limited number of its pharmacies either in person or via mail delivery.
Now, nearly two dozen state attorneys general have written to CVS and Walgreens executives, warning that the new Food and Drug Administration regulation apparently permitting this distribution could bring trouble for pharmacies that follow it, particularly if they use mail delivery.
Comments